- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01430377
Side Branch Predilatation Strategy in Coronary Bifurcation Lesion Stenting (SBPS) (SBPS)
September 7, 2011 updated by: Dobrin Vassilev MD, PhD, Medica Cor Heart Hospital
The role of Side Branch (SB) predilatation during coronary bifurcation lesion percutaneous coronary intervention (PCI) is still not established.
The predilatation could potentially damage SB ostium by vessel dissection, making subsequent wiring problematic.
However, predilatation could eliminate SB ostial stenosis obviating need for further SB treatment after main vessel stent implantation.
The aim of the study is to assess in random fashion the periprocedural myonecrosis, complication rates and time for SB rewiring in groups with and without SB predilatation.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
120
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ruse, Bulgaria, 7000
- Recruiting
- Medica Cor Heart Hospital
-
Contact:
- Dobrin I Vassilev, MD, PhD
- Phone Number: 00359886846550
- Email: dobrinv@gmail.com
-
Contact:
- Hristo Popov, MD
- Phone Number: 00359887686003
- Email: hrpopov@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria
- Subject at least 18 years of age.
- Subject able to verbally confirm understandings of risks, benefits of receiving PCI for true bifurcation lesions, and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
- Target main branch lesion(s) located in a native coronary artery with diameter of ≥ 2.5 mm and ≤ 4.5 mm. Target side branch lesion(s) located in a native coronary artery with diameter of ≥ 2.0 mm.
- Target lesion(s) amenable for PCI with balloon angioplasty of the side branch.
Exclusion Criteria
- ST-segment elevation myocardial infarction (STEMI)
- Non-cardiac co-morbid conditions are present with life expectancy <1 year or that may result in protocol non-compliance (per site investigator's medical judgment).
- Subjects who refuse to give informed consent.
- Subjects with left ventricle ejection fraction <30%
- Subjects with moderate or severe degree valvular heart disease or primary cardiomyopathy
- Contraindications for 12 months double antiplatelet therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: SB predilatation
|
Initial SB [predilatation.
Without SB predilatation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Time for rewiring SB
Time Frame: 24h
|
24h
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Periprocedural myonecrosis
Time Frame: 24 h
|
24 h
|
|
MACE
Time Frame: 12 months
|
death, MI, TVR
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2011
Primary Completion (Anticipated)
April 1, 2012
Study Completion (Anticipated)
May 1, 2012
Study Registration Dates
First Submitted
September 3, 2011
First Submitted That Met QC Criteria
September 7, 2011
First Posted (Estimate)
September 8, 2011
Study Record Updates
Last Update Posted (Estimate)
September 8, 2011
Last Update Submitted That Met QC Criteria
September 7, 2011
Last Verified
September 1, 2011
More Information
Terms related to this study
Other Study ID Numbers
- SBPS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Ostium Stenosis
-
Biotronik (Beijing) Medical Device Ltd.Biotronik AGEnrolling by invitationNative Coronary Artery Stenosis | In-Stent Stenosis (Restenosis) of Coronary Artery StentChina
-
Axetis AGUnknownNative Coronary Artery StenosisNetherlands
-
Fundación Pública Andaluza Progreso y SaludUnknownUnprotected Left Main Coronary Artery StenosisSpain
-
ECRI bvBoston Scientific Corporation; Philips HealthcareActive, not recruitingLeft Main Coronary Artery StenosisSpain, United Kingdom, Italy
-
Institut Mutualiste MontsourisCompletedLeft Main Coronary Artery StenosisFrance
-
Tryton Medical, Inc.UnknownLeft Main Coronary Artery StenosisGermany
-
Columbia UniversityRecruitingLeft Anterior Descending Coronary Artery StenosisUnited States
-
San Luigi Gonzaga HospitalRecruitingCoronary Disease | STEMI | Coronary Artery Ectasia | Right Coronary Artery Occlusion | Right Coronary Artery StenosisSpain, Italy
-
Concept Medical Inc.Cardiovascular Research Foundation, New YorkNot yet recruitingCardiovascular Diseases | Coronary Artery Disease | Native Coronary Artery Stenosis
-
Boston Scientific CorporationCompletedAtherosclerotic Lesions in the Aortorenal OstiumUnited States
Clinical Trials on SB predilatation
-
Cardiology Center AgelUnknownCoronary Artery Stenosis
-
SIS Medical AGUnknownCoronary Artery Disease | Stable Angina | Unstable Angina | AnginaSwitzerland
-
University of MinnesotaRecruitingCardiovascular Diseases | Type 2 DiabetesUnited States
-
GlaxoSmithKlineCompletedSchizophreniaUnited Kingdom
-
Sangamo TherapeuticsActive, not recruitingHemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis IIUnited States
-
Nguyen Thi Trieu, MDCompletedCirrhosis of the LiverVietnam
-
GlaxoSmithKlineCompletedAtherosclerosisNetherlands, Belgium, Germany, Czechia, France, Austria, Spain, Norway, Poland, Denmark, Switzerland
-
GlaxoSmithKlineCompletedChronic Idiopathic Thrombocytopenic Purpura | Purpura, Thrombocytopenic, IdiopathicJapan
-
Boston Medical CenterNational Institute of Mental Health (NIMH)Completed
-
Case Comprehensive Cancer CenterActive, not recruitingAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic... and other conditionsUnited States